Chuck Royce's BLFS Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 584,011 shares of BioLife Solutions, Inc. (BLFS) worth $11.14 M, representing 0.11% of the portfolio. First purchased in 2019-Q2, this long-term strategic position has been held for 26 quarters.
Based on 13F filings, Chuck Royce has maintained a strategic position in BLFS, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2023, adding 628,827 shares. Largest reduction occurred in Q1 2021, reducing 543,620 shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's BioLife Solutions (BLFS) Holding Value Over Time
Track share changes against reported price movement
Quarterly BioLife Solutions (BLFS) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +166,921 | Add 40.02% | 584,011 | $19.08 |
| Q4 2025 | -54,839 | Reduce 11.62% | 417,090 | $24.18 |
| Q3 2025 | -49,876 | Reduce 9.56% | 471,929 | $25.51 |
| Q2 2025 | -338,939 | Reduce 39.38% | 521,805 | $21.54 |
| Q1 2025 | +83,462 | Add 10.74% | 860,744 | $22.84 |
| Q4 2024 | -47,851 | Reduce 5.80% | 777,282 | $25.96 |
| Q3 2024 | -87,519 | Reduce 9.59% | 825,133 | $25.04 |
| Q2 2024 | +397,445 | Add 77.14% | 912,652 | $21.43 |
| Q1 2024 | -356,396 | Reduce 40.89% | 515,207 | $18.55 |
| Q4 2023 | +628,827 | Add 259.02% | 871,603 | $16.25 |
| Q3 2023 | +242,776 | New Buy | 242,776 | $13.81 |
| Q4 2022 | -21,600 | Sold Out | 0 | $0.00 |
| Q3 2022 | -200 | Reduce 0.92% | 21,600 | $22.73 |
| Q2 2022 | +21,800 | New Buy | 21,800 | $13.81 |
| Q1 2022 | -57,300 | Sold Out | 0 | $0.00 |
| Q4 2021 | -129,856 | Reduce 69.38% | 57,300 | $37.28 |
| Q3 2021 | +1,960 | Add 1.06% | 187,156 | $42.32 |
| Q2 2021 | -116,300 | Reduce 38.57% | 185,196 | $44.51 |
| Q1 2021 | -543,620 | Reduce 64.32% | 301,496 | $36.00 |
| Q3 2020 | +165,500 | Add 24.35% | 845,116 | $28.94 |
| Q2 2020 | +198,900 | Add 41.38% | 679,616 | $16.35 |
| Q1 2020 | +260,000 | Add 117.80% | 480,716 | $9.50 |
| Q4 2019 | +24,061 | Add 12.24% | 220,716 | $16.18 |
| Q3 2019 | +10,000 | Add 5.36% | 196,655 | $16.62 |
| Q2 2019 | +186,655 | New Buy | 186,655 | $16.95 |
Chuck Royce's BioLife Solutions Investment FAQs
Chuck Royce first purchased BioLife Solutions, Inc. (BLFS) in Q2 2019, acquiring 186,655 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held BioLife Solutions, Inc. (BLFS) for 26 quarters since Q2 2019.
Chuck Royce's largest addition to BioLife Solutions, Inc. (BLFS) was in Q4 2023, adding 871,603 shares worth $14.16 M.
According to the latest 13F filing for Q1 2026, Chuck Royce's firm, Royce & Associates Lp, owns 584,011 shares of BioLife Solutions, Inc. (BLFS), valued at approximately $11.14 M.
As of the Q1 2026 filing, BioLife Solutions, Inc. (BLFS) represents approximately 0.11% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in BioLife Solutions, Inc. (BLFS) was 912,652 shares, as reported at the end of Q2 2024.